Data search
Results for MligTC455_37286
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_37286 | 90 | 1.88 | Mlig455_025470, Mlig455_071141 | Neo: - Age: - |
GRIA2 | Mlig455_025470 {REF} {Length: 3546} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.8]; Receptor family ligand binding region [PF01094.30, score=50.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.9]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=120, Expect=2e-27]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=119, Expect=7e-27]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=118, Expect=2e-26]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=117, Expect=4e-26]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=116, Expect=6e-26]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=115, Expect=1e-25]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=115, Expect=2e-25]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=118, Expect=1e-26]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=118, Expect=9e-27]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=117, Expect=2e-26]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=116, Expect=4e-26]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=116, Expect=4e-26]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=115, Expect=6e-26]} {Dmel: FBgn0038837, CG3822, [Score=153, Expect=5e-38]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=228, Expect=9e-67]} {RNA1310_33468} Mlig455_071141 {REF} {Length: 3783} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.8]; Receptor family ligand binding region [PF01094.30, score=50.3]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.8]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=118, Expect=2e-26]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=118, Expect=2e-26]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=115, Expect=1e-25]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=115, Expect=2e-25]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=114, Expect=2e-25]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=113, Expect=5e-25]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=117, Expect=3e-26]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=117, Expect=1e-26]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=115, Expect=5e-26]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=115, Expect=6e-26]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=113, Expect=3e-25]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=112, Expect=6e-25]} {Dmel: FBgn0038837, CG3822, [Score=154, Expect=4e-38]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=228, Expect=7e-67]} {RNA1310_33468} |
Cumulative graph for MligTC455_37286
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -0.35 | 1.862 | 1.00000 | 1.00000 | |
| RegionR2 | 3.206 | 1.862 | 0.43663 | 0.82637 | |
| RegionR3 | -1.082 | 1.862 | 0.95423 | 1.00000 | |
| RegionR4 | 0.313 | 1.862 | 0.63228 | 0.94056 | |
| RegionR5 | -1.126 | 1.862 | 0.93937 | 1.00000 | |
| RegionR6 | 0.692 | 1.862 | 0.79990 | 1.00000 | |
| RegionR7 | -3.383 | 1.862 | 0.99988 | 1.00000 | |
| RegionR8 | 1.731 | 1.862 | 0.59739 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -2.558 | 1.862 | 1.00000 | 1.00000 | |
| RegenerationR2 | -0.767 | 1.862 | 0.81506 | 0.99439 | |
| RegenerationR3 | 0.543 | 1.862 | 0.96039 | 1.00000 | |
| RegenerationR4 | 0.549 | 1.862 | 0.97890 | 1.00000 | |
| RegenerationR5 | 2.687 | 1.862 | 0.31450 | 0.73922 | |
| RegenerationR6 | -1.238 | 1.862 | 0.69140 | 0.91962 | |
| RegenerationBL | 1.514 | 1.862 | 0.47836 | 0.84382 | |
| RegenerationTP | -3.127 | 1.862 | 0.99992 | 1.00000 |
Genes with expression patterns similar to MligTC455_37286
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_37286 | 90 | 1.88 | Mlig455_025470, Mlig455_071141 | Neo: - Age: - |
GRIA2 | 5 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | - | Mlig455_025470 {REF} {Length: 3546} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.8]; Receptor family ligand binding region [PF01094.30, score=50.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.9]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=120, Expect=2e-27]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=119, Expect=7e-27]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=118, Expect=2e-26]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=117, Expect=4e-26]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=116, Expect=6e-26]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=115, Expect=1e-25]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=115, Expect=2e-25]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=118, Expect=1e-26]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=118, Expect=9e-27]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=117, Expect=2e-26]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=116, Expect=4e-26]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=116, Expect=4e-26]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=115, Expect=6e-26]} {Dmel: FBgn0038837, CG3822, [Score=153, Expect=5e-38]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=228, Expect=9e-67]} {RNA1310_33468} Mlig455_071141 {REF} {Length: 3783} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.8]; Receptor family ligand binding region [PF01094.30, score=50.3]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.8]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=118, Expect=2e-26]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=118, Expect=2e-26]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=115, Expect=1e-25]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=115, Expect=2e-25]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=114, Expect=2e-25]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=113, Expect=5e-25]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=117, Expect=3e-26]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=117, Expect=1e-26]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=115, Expect=5e-26]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=115, Expect=6e-26]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=113, Expect=3e-25]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=112, Expect=6e-25]} {Dmel: FBgn0038837, CG3822, [Score=154, Expect=4e-38]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=228, Expect=7e-67]} {RNA1310_33468} |
| 2. | MligTC455_40406 | 59 | 1.23 | Mlig455_062481 | Neo: - Age: - |
CHRNA9 | 4.263 | 0.834 | 0.857 | 0.782 | 0.824 | 0.966 | - | Mlig455_062481 {REF} {Length: 3660} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=205, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=201, Expect=7e-58]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=2e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=199, Expect=2e-57]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=199, Expect=4e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=196, Expect=1e-54]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=4e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=207, Expect=7e-60]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=200, Expect=6e-58]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=202, Expect=2e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=192, Expect=7e-55]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=449, Expect=5e-153]} {RNA1509_18288} {RNA1310_3728, RNA1509_18288} {RNA1509_18288, RNA815_3826.3} |
| 3. | MligTC455_22077 | 58 | 1.2 | Mlig455_041277 | Neo: - Age: - |
3.802 | - | 0.944 | 0.997 | 0.903 | 0.958 | - | Mlig455_041277 {REF} {Length: 1351} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=30.4]} {RNA1310_27422} {RNA815_33833} | |
| 4. | MligTC455_45351 | 241 | 5.02 | Mlig455_031191 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.622/0.00310 |
3.8 | - | 0.931 | 0.987 | 0.929 | 0.953 | - | Mlig455_031191 {REF} {Length: 2855} {Pfam: Srg family chemoreceptor [PF02118.23, score=28.1]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=26.4]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=26.4]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=49.3, Expect=2e-06]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [Score=54.7, Expect=4e-08]} {RNA1509_20184} {RNA1310_32455} {RNA815_38062} | |
| 5. | MligTC455_43714 | 152 | 3.18 | Mlig455_000684, Mlig455_000736 | Neo: - Age: - |
3.778 | - | 0.944 | 0.998 | 0.915 | 0.921 | - | Mlig455_000684 {REF} {Length: 796} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} Mlig455_000736 {REF} {Length: 797} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} |
|
| 6. | MligTC455_49451 | 16 | 0.34 | Mlig455_030374 | Neo: - Age: - |
NOX5 | 3.774 | - | 0.944 | 0.971 | 0.910 | 0.949 | - | Mlig455_030374 {REF} {Length: 890} {Pfam: EF hand [PF00036.34, score=93.4]; EF-hand domain [PF13405.8, score=86.0]; EF hand [PF13202.8, score=73.1]; EF-hand domain pair [PF13499.8, score=70.3]; EF-hand domain pair [PF13833.8, score=49.3]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=29.0]; EF-hand domain [PF14658.8, score=23.2]; Caleosin related protein [PF05042.15, score=20.4]; EF-hand domain [PF17958.3, score=19.8]} {Human: ENSG00000255346, NOX5, NADPH oxidase 5, [Score=67.4, Expect=2e-13]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.5, Expect=3e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=63.2, Expect=4e-13]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=63.2, Expect=4e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=63.2, Expect=4e-13]} {Dmel: FBgn0033238, azot, ahuizotl, [Score=64.3, Expect=1e-13]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=62.4, Expect=6e-13]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=101, Expect=2e-28]} {RNA1310_74457} |
| 7. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
3.768 | - | 0.941 | 0.970 | 0.912 | 0.945 | - | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
| 8. | MligTC455_43715 | 48 | 0.99 | Mlig455_034191 | Neo: - Age: Down-Up-Down Region-enriched R2: 7.969/0.00817 |
3.764 | - | 0.970 | 0.953 | 0.893 | 0.948 | - | Mlig455_034191 {REF} {Length: 895} {Pfam: WSC domain [PF01822.21, score=39.9]; PAN domain [PF14295.8, score=21.0]; PAN domain [PF00024.28, score=19.9]} {RNA1310_46313} {RNA815_23250} | |
| 9. | MligTC455_18945 | 41 | 0.86 | Mlig455_031602 | Neo: - Age: - |
3.761 | - | 0.904 | 0.984 | 0.915 | 0.958 | - | Mlig455_031602 {REF} {Length: 914} {RNA1310_75361} {RNA815_24378} | |
| 10. | MligTC455_48656 | 24 | 0.5 | Mlig455_039647 | Neo: - Age: - |
3.761 | - | 0.944 | 0.962 | 0.905 | 0.950 | - | Mlig455_039647 {REF} {Length: 1715} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.7]} {RNA1310_48037} {RNA815_27969} | |
| 11. | MligTC455_47780 | 214 | 4.46 | Mlig455_018842, Mlig455_018853 | Neo: - Age: - |
3.735 | - | 0.950 | 0.955 | 0.897 | 0.933 | - | Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082} Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082} |
|
| 12. | MligTC455_12512 | 80 | 1.68 | Mlig455_017689 | Neo: - Age: - |
3.734 | - | 0.944 | 0.967 | 0.880 | 0.943 | - | Mlig455_017689 {REF} {Length: 934} {RNA1310_37507} {RNA815_32171} | |
| 13. | MligTC455_10966 | 15 | 0.31 | Mlig455_013154 | Neo: - Age: - |
3.733 | - | 0.927 | 0.975 | 0.879 | 0.952 | - | Mlig455_013154 {REF} {Length: 827} {Pfam: Lectin C-type domain [PF00059.23, score=21.8]} {RNA1509_20946} {RNA1310_65161} {RNA815_4785.1} | |
| 14. | MligTC455_17578 | 447 | 9.32 | Mlig455_010738 | Neo: - Age: Down-Up-Up Region-specific R2: 8.320 Region-enriched R2: 9.793/0.00000 |
3.721 | - | 0.912 | 0.996 | 0.909 | 0.904 | - | Mlig455_010738 {REF} {Length: 642} {RNA1509_48297, RNA1509_55742} {RNA1310_84623, RNA1509_48297, RNA1509_55742} {RNA1509_48297, RNA1509_55742, RNA815_45356} | |
| 15. | MligTC455_19552 | 288 | 6 | Mlig455_055936, Mlig455_068188 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.424 Region-specific R2: 6.302 Region-enriched R2: 4.919/0.00633 Regeneration-depleted R4: -5.607 |
3.719 | - | 0.958 | 0.919 | 0.893 | 0.949 | - | Mlig455_055936 {REF} {Length: 665} {RNA1310_71052} {RNA815_36745} Mlig455_068188 {REF} {Length: 714} {RNA1310_71052} {RNA815_36745} |
|
| 16. | MligTC455_48713 | 380 | 7.92 | Mlig455_009259, Mlig455_009268 | Neo: - Age: Down-Up-Down Region-specific R2: 6.962 Region-enriched R2: 4.845/0.00046 |
3.704 | - | 0.908 | 0.979 | 0.894 | 0.923 | - | Mlig455_009259 {REF} {Length: 654} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} Mlig455_009268 {REF} {Length: 546} {RNA1509_35038} {RNA1310_72135, RNA1509_35038} {RNA1509_35038, RNA815_37404} |
|
| 17. | MligTC455_33440 | 62 | 1.29 | Mlig455_053806, Mlig455_053807 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.142/0.02950 |
GRID1 | 3.683 | - | 0.920 | 0.999 | 0.818 | 0.946 | - | Mlig455_053806 {REF} {Length: 3070} {Pfam: Ligand-gated ion channel [PF00060.28, score=72.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.7]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=39.8]; Receptor family ligand binding region [PF01094.30, score=28.6]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=145, Expect=2e-35]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=143, Expect=2e-34]} {Dmel: FBgn0038837, CG3822, [Score=126, Expect=2e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=257, Expect=1e-77]} {RNA1310_13880.2} {RNA815_12458} Mlig455_053807 {REF} {Length: 3142} {Pfam: Ligand-gated ion channel [PF00060.28, score=79.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=38.3]; Receptor family ligand binding region [PF01094.30, score=36.5]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=139, Expect=2e-33]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=137, Expect=1e-32]} {Dmel: FBgn0038837, CG3822, [Score=125, Expect=5e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=117, Expect=1e-26]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=259, Expect=2e-78]} {RNA1310_13880.2} {RNA815_12458} |
| 18. | MligTC455_48714 | 132 | 2.74 | Mlig455_037041 | Neo: - Age: - Region-enriched R2: 4.531/0.00493 |
3.678 | - | 0.935 | 0.960 | 0.822 | 0.961 | - | Mlig455_037041 {REF} {Length: 1099} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} | |
| 19. | MligTC455_12511 | 68 | 1.42 | Mlig455_017662 | Neo: - Age: - |
3.669 | - | 0.940 | 0.977 | 0.802 | 0.950 | - | Mlig455_017662 {REF} {Length: 906} {RNA1310_37507} {RNA815_32171} | |
| 20. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
3.667 | - | 0.914 | 0.893 | 0.897 | 0.963 | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
| 21. | MligTC455_43072 | 81 | 1.68 | Mlig455_042521 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.590/0.02161 |
3.661 | - | 0.952 | 0.936 | 0.924 | 0.849 | - | Mlig455_042521 {REF} {Length: 1049} {RNA1509_46101} {RNA1310_32444} {RNA815_30668} | |
| 22. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
3.614 | - | 0.878 | 0.867 | 0.917 | 0.952 | - | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
| 23. | MligTC455_18607 | 203 | 4.23 | Mlig455_012344, Mlig455_012722 | Neo: - Age: - Region-enriched R2: 3.338/0.02204 |
ANKRD63 | 3.601 | - | 0.932 | 0.897 | 0.808 | 0.964 | - | Mlig455_012344 {REF} {Length: 1989} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.3]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=55.5, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_1, dd_Smed_v6_11187_0_1, [Score=59.3, Expect=2e-09]} {RNA1310_37830} {RNA815_38436} Mlig455_012722 {REF} {Length: 2256} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.2]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0031473, CG3104, [Score=54.7, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_2, dd_Smed_v6_11187_0_2, [Score=59.7, Expect=1e-09]} {RNA1310_37830} {RNA815_38436} |
| 24. | MligTC455_50455 | 972 | 20.25 | Mlig455_070346 | Neo: - Age: - Region-specific R2: 4.855 Region-enriched R2: 5.186/0.00000 |
3.599 | - | 0.922 | 0.860 | 0.860 | 0.957 | - | Mlig455_070346 {REF} {Length: 932} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=34.4]; Nematode insulin-related peptide beta type [PF03488.16, score=21.4]} {RNA1509_18514, RNA1509_58074} {RNA1310_51990, RNA1509_18514, RNA1509_58074} {RNA1509_18514, RNA1509_58074, RNA815_25071} | |
| 25. | MligTC455_10899 | 46 | 0.95 | Mlig455_013784, Mlig455_013915 | Neo: - Age: - |
3.595 | - | 0.944 | 0.950 | 0.845 | 0.856 | - | Mlig455_013784 {REF} {Length: 1362} {Pfam: Glycine rich protein [PF12810.9, score=20.8]} {RNA1509_28715} {RNA1310_91773} {RNA815_35307} Mlig455_013915 {REF} {Length: 1516} {Pfam: Glycine rich protein [PF12810.9, score=20.3]} {RNA1509_28715} {RNA1310_91773} {RNA815_35307} |
|
| 26. | MligTC455_19708 | 304 | 6.32 | Mlig455_009784 | Neo: - Age: - Region-enriched R2: 6.355/0.00039 |
3.592 | - | 0.944 | 0.964 | 0.924 | 0.760 | - | Mlig455_009784 {REF} {Length: 826} {Pfam: Pancreatic hormone peptide [PF00159.20, score=43.3]} {RNA1509_54211} {RNA1310_54505.1, RNA1509_54211} {RNA1509_54211, RNA815_29389} | |
| 27. | MligTC455_37188 | 31 | 0.65 | Mlig455_000345 | Neo: - Age: - |
TRAF5 | 3.588 | - | 0.946 | 0.792 | 0.889 | 0.961 | - | Mlig455_000345 {REF} {Length: 892} {Human: ENSG00000082512, TRAF5, TNF receptor associated factor 5, [Score=67.8, Expect=2e-12]; ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=65.5, Expect=8e-12]} {Mouse: ENSMUSG00000111385, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]; ENSMUSG00000026637, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=65.1, Expect=6e-12]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [Score=92.0, Expect=3e-21]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [Score=108, Expect=5e-27]} |
| 28. | MligTC455_29100 | 53 | 1.11 | Mlig455_022386, Mlig455_022475 | Neo: - Age: - Region-enriched R2: 7.567/0.00114 |
KREMEN2 | 3.58 | - | 0.833 | 0.967 | 0.851 | 0.929 | - | Mlig455_022386 {REF} {Length: 4145} {tRNA: Val(CAC),pseudo, score=29.3} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=48.5, Expect=3e-06]; ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=47.0, Expect=7e-06]} {RNA1509_55375} {RNA1310_18706} {RNA815_23500} Mlig455_022475 {REF} {Length: 3047} {Pfam: WSC domain [PF01822.21, score=46.0]; PAN domain [PF00024.28, score=23.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=51.2, Expect=4e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=53.5, Expect=5e-08]} {RNA1509_47157} {RNA1310_35396.1} {RNA815_23500} |
| 29. | MligTC455_43963 | 1010 | 21.04 | Mlig455_015437 | Neo: - Age: Down-Down-Up Region-enriched R2: 2.083/0.01168 |
3.58 | - | 0.951 | 0.956 | 0.770 | 0.903 | - | Mlig455_015437 {REF} {Length: 612} {RNA1509_32160} {RNA1310_60746, RNA1509_32160} {RNA1509_32160, RNA815_30740} | |
| 30. | MligTC455_16358 | 1175 | 24.47 | Mlig455_039878 | Neo: - Age: - Region-specific R2: 4.659 Region-enriched R2: 4.310/0.00000 |
3.568 | - | 0.897 | 0.817 | 0.887 | 0.967 | - | Mlig455_039878 {REF} {Length: 1188} {RNA1509_60020} {RNA1310_35099.1, RNA1509_60020} {RNA1509_60020, RNA815_1356.1} | |
| 31. | MligTC455_31933 | 105 | 2.18 | Mlig455_062083 | Neo: - Age: - |
ANGPTL1 | 3.568 | - | 0.982 | 0.954 | 0.713 | 0.919 | - | Mlig455_062083 {REF} {Length: 1024} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=156.7]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=135, Expect=7e-36]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=132, Expect=2e-34]; ENSG00000101280, ANGPT4, angiopoietin 4, [Score=132, Expect=9e-35]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=137, Expect=1e-36]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=132, Expect=4e-35]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=131, Expect=1e-34]} {Dmel: FBgn0034160, CG5550, [Score=130, Expect=2e-36]} {Celegans: WBGene00020516, T15B7.1, [Score=73.9, Expect=9e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=126, Expect=2e-32]} {RNA1509_14033} {RNA1310_32107.2} {RNA815_17173.3} |
| 32. | MligTC455_17299 | 538 | 11.21 | Mlig455_036559, Mlig455_057787 | Neo: - Age: - Region-enriched R2: 5.046/0.00000 |
3.557 | - | 0.931 | 0.768 | 0.886 | 0.972 | - | Mlig455_036559 {REF} {Length: 718} {RNA1509_57277} {RNA1310_52579, RNA1509_57277} {RNA1509_57277, RNA815_26706} Mlig455_057787 {REF} {Length: 741} {RNA1509_57277} {RNA1310_52579} {RNA815_26706} |
|
| 33. | MligTC455_23150 | 3195 | 66.56 | Mlig455_009524, Mlig455_009530 | Neo: - Age: - Region-enriched R2: 3.504/0.00000 |
CDK16 | 3.539 | - | 0.961 | 0.946 | 0.830 | 0.802 | - | Mlig455_009524 {REF} {Length: 3287} {Pfam: Protein kinase domain [PF00069.27, score=218.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=114.2]} {Human: ENSG00000102225, CDK16, cyclin dependent kinase 16, [RH, Score=463, Expect=7e-159]; ENSG00000059758, CDK17, cyclin dependent kinase 17, [RH, Score=447, Expect=2e-151]} {Mouse: ENSMUSG00000031065, Cdk16, cyclin-dependent kinase 16, [RH, Score=464, Expect=2e-158]; ENSMUSG00000020015, Cdk17, cyclin-dependent kinase 17, [RH, Score=449, Expect=2e-152]} {Dmel: FBgn0005640, Eip63E, Ecdysone-induced protein 63E, [Score=362, Expect=2e-118]} {Celegans: WBGene00003961, pct-1, Cyclin-dependent kinase 17, [RH, Score=417, Expect=3e-138]} {Smed: dd_Smed_v6_4172_0_4, dd_Smed_v6_4172_0_4, [RH, Score=449, Expect=6e-151]} {RNA1509_23462} {RNA1310_21506} {RNA815_9702} Mlig455_009530 {REF} {Length: 3384} {Pfam: Protein kinase domain [PF00069.27, score=208.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=114.4]; Haspin like kinase domain [PF12330.10, score=17.8]} {Human: ENSG00000102225, CDK16, cyclin dependent kinase 16, [Score=432, Expect=5e-147]} {Mouse: ENSMUSG00000031065, Cdk16, cyclin-dependent kinase 16, [Score=431, Expect=4e-146]} {Dmel: FBgn0005640, Eip63E, Ecdysone-induced protein 63E, [Score=329, Expect=9e-107]} {Celegans: WBGene00003961, pct-1, Cyclin-dependent kinase 17, [Score=392, Expect=2e-130]} {Smed: dd_Smed_v6_4172_0_4, dd_Smed_v6_4172_0_4, [Score=411, Expect=6e-137]} {RNA1509_23462} {RNA1310_21506} {RNA815_9702} |
| 34. | MligTC455_29118 | 467 | 9.72 | Mlig455_040411 | Neo: - Age: - Region-specific R2: 6.456 Region-enriched R2: 5.344/0.00023 |
3.534 | - | 0.959 | 0.855 | 0.904 | 0.816 | - | Mlig455_040411 {REF} {Length: 599} {TRANSSPLICED} {RNA1509_53840} {RNA1310_67192, RNA1509_53840} {RNA1509_53840, RNA815_27042} | |
| 35. | MligTC455_48064 | 23 | 0.48 | Mlig455_061550 | Neo: - Age: - |
3.532 | - | 1.000 | 0.917 | 0.881 | 0.734 | - | Mlig455_061550 {REF} {Length: 860} {RNA1310_88363} {RNA815_47885} | |
| 36. | MligTC455_25928 | 181 | 3.78 | Mlig455_006534, Mlig455_006538, Mlig455_006649, Mlig455_006700 | Neo: - Age: logFC(26M/2M)=-0.528 Region-specific R2: 7.256 Region-enriched R2: 5.788/0.02697 |
3.515 | 0.888 | 0.953 | - | 0.861 | 0.813 | - | Mlig455_006534 {REF} {Length: 689} {RNA1509_22927} {RNA1310_81957.1} {RNA815_41771.2} Mlig455_006538 {REF} {Length: 1691} {RNA1509_12380} {RNA1310_164.2} {RNA815_19957} Mlig455_006649 {REF} {Length: 829} {RNA1509_22927} {RNA1310_81957.1} {RNA815_41771.2} Mlig455_006700 {REF} {Length: 750} {RNA1509_22927} {RNA1310_81957.2} {RNA815_41771.2} |
|
| 37. | MligTC455_34810 | 109 | 2.27 | Mlig455_024348, Mlig455_024465 | Neo: - Age: - Region-enriched R2: 5.365/0.04615 |
3.514 | - | 0.859 | 0.773 | 0.924 | 0.958 | - | Mlig455_024348 {REF} {Length: 934} {RNA1310_67817} {RNA815_52313} Mlig455_024465 {REF} {Length: 1036} {RNA1310_67817} {RNA815_52313} |
|
| 38. | MligTC455_14598 | 52 | 1.07 | Mlig455_058970 | Neo: - Age: - |
3.51 | - | 0.950 | 0.917 | 0.786 | 0.857 | - | Mlig455_058970 {REF} {Length: 1038} {RNA1310_39570} {RNA815_52309} | |
| 39. | MligTC455_15329 | 22 | 0.47 | Mlig455_060498 | Neo: - Age: - |
3.506 | - | 0.791 | 0.959 | 0.850 | 0.906 | - | Mlig455_060498 {REF} {Length: 1186} {Pfam: PAN domain [PF00024.28, score=18.9]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=63.9, Expect=4e-12]} {RNA1310_37660} {RNA815_17816.1} | |
| 40. | MligTC455_41130 | 1186 | 24.72 | Mlig455_000166, Mlig455_000179, Mlig455_067712 | Neo: - Age: Down-Up-Down Region-specific R2: 5.626 Region-enriched R2: 4.906/0.00009 Regeneration-downregulated R3: -5.200 Regeneration-depleted R3: -5.200 |
3.499 | - | 0.951 | 0.836 | 0.786 | 0.926 | - | Mlig455_000166 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_000179 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_067712 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} |
|
| 41. | MligTC455_43173 | 392 | 8.16 | Mlig455_037383 | Neo: - Age: Up-Down-Down Regeneration-downregulated TP: -5.031 Regeneration-depleted TP: -5.031 |
C2orf16 | 3.484 | - | 0.730 | 0.951 | 0.912 | 0.891 | - | Mlig455_037383 {REF} {Length: 2450} {Pfam: Cornifin (SPRR) family [PF02389.17, score=23.4]} {Human: ENSG00000221843, C2orf16, chromosome 2 open reading frame 16, [Score=80.1, Expect=7e-15]} {RNA1509_52401} {RNA1310_14622.1} {RNA815_17994} |
| 42. | MligTC455_19775 | 36 | 0.74 | Mlig455_060359 | Neo: - Age: - |
FCN1 | 3.478 | - | 0.944 | 0.971 | 0.736 | 0.827 | - | Mlig455_060359 {REF} {Length: 1109} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.9]} {Human: ENSG00000085265, FCN1, ficolin 1, [Score=99.0, Expect=2e-23]; ENSG00000142748, FCN3, ficolin 3, [Score=99.0, Expect=1e-23]; ENSG00000160339, FCN2, ficolin 2, [Score=98.2, Expect=2e-23]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=100, Expect=3e-24]} {Dmel: FBgn0034160, CG5550, [Score=97.8, Expect=7e-24]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=90.1, Expect=4e-20]} {RNA1310_67383} {RNA815_45536} |
| 43. | MligTC455_17562 | 108 | 2.25 | Mlig455_022496 | Neo: - Age: - |
NECAB3 | 3.444 | 0.769 | - | 0.856 | 0.859 | 0.960 | - | Mlig455_022496 {REF} {Length: 1499} {Pfam: EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF-hand domain pair [PF13499.8, score=28.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=22.0]; EF hand [PF13202.8, score=21.3]} {Human: ENSG00000125967, NECAB3, N-terminal EF-hand calcium binding protein 3, [RH, Score=189, Expect=7e-57]; ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [RH, Score=191, Expect=7e-58]; ENSMUSG00000027489, Necab3, N-terminal EF-hand calcium binding protein 3, [RH, Score=191, Expect=9e-58]} {RNA1509_46831} {RNA1310_24461} {RNA815_25216} |
| 44. | MligTC455_12180 | 107 | 2.23 | Mlig455_038554, Mlig455_052202, Mlig455_053449 | Neo: - Age: logFC(26M/2M)=-0.655 Region-enriched R2: 5.717/0.01573 |
CNGA3 | 3.311 | - | 0.739 | 0.773 | 0.839 | 0.960 | - | Mlig455_038554 {REF} {Length: 2866} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=75.9]; Cyclic nucleotide-binding domain [PF00027.31, score=69.1]; Ion transport protein [PF00520.33, score=68.6]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [RH, Score=650, Expect=0.0]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [RH, Score=644, Expect=0.0]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [RH, Score=607, Expect=0.0]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [RH, Score=563, Expect=0.0]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [RH, Score=669, Expect=0.0]} {RNA1310_22950} {RNA815_16119} Mlig455_052202 {REF} {Length: 3203} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=76.1]; Cyclic nucleotide-binding domain [PF00027.31, score=69.1]; Ion transport protein [PF00520.33, score=68.2]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [RH, Score=650, Expect=0.0]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [RH, Score=644, Expect=0.0]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [RH, Score=605, Expect=0.0]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [RH, Score=563, Expect=0.0]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [RH, Score=667, Expect=0.0]} {RNA1310_22950} {RNA815_16119} Mlig455_053449 {REF} {Length: 991} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=79.9]; Cyclic nucleotide-binding domain [PF00027.31, score=29.1]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=171, Expect=7e-50]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=161, Expect=2e-46]; ENSMUSG00000067220, Cnga1, cyclic nucleotide gated channel alpha 1, [Score=155, Expect=4e-44]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [Score=148, Expect=1e-41]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=149, Expect=3e-42]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=155, Expect=8e-45]} {RNA1310_61700} {RNA815_16119} |
| 45. | MligTC455_42245 | 15 | 0.32 | Mlig455_000580 | Neo: - Age: - |
NOX5 | 2.842 | - | 0.944 | 0.991 | 0.907 | - | - | Mlig455_000580 {REF} {Length: 884} {Pfam: EF hand [PF00036.34, score=93.4]; EF-hand domain [PF13405.8, score=85.2]; EF hand [PF13202.8, score=73.1]; EF-hand domain pair [PF13499.8, score=71.3]; EF-hand domain pair [PF13833.8, score=47.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=29.8]; EF-hand domain [PF14658.8, score=21.3]; Caleosin related protein [PF05042.15, score=20.9]; EF-hand domain [PF17958.3, score=19.9]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=19.5]} {Human: ENSG00000255346, NOX5, NADPH oxidase 5, [Score=68.6, Expect=9e-14]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=62.0, Expect=1e-12]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=60.5, Expect=5e-12]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=60.5, Expect=5e-12]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=60.5, Expect=5e-12]} {Dmel: FBgn0033238, azot, ahuizotl, [Score=62.4, Expect=7e-13]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=59.3, Expect=8e-12]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=102, Expect=1e-28]} {RNA1310_74457} |
| 46. | MligTC455_11765 | 292 | 6.08 | Mlig455_032580, Mlig455_032642 | Neo: - Age: - Region-specific R2: 6.434 Region-enriched R2: 4.662/0.03055 |
2.835 | - | 0.943 | - | 0.926 | 0.966 | - | Mlig455_032580 {REF} {Length: 565} {RNA1509_42630} {RNA1310_64208} {RNA815_32993} Mlig455_032642 {REF} {Length: 663} {RNA1509_42630} {RNA1310_64208} {RNA815_32993} |
|
| 47. | MligTC455_15727 | 112 | 2.33 | Mlig455_027846, Mlig455_060005 | Neo: - Age: - |
2.835 | - | 0.973 | 0.988 | 0.874 | - | - | Mlig455_027846 {REF} {Length: 910} {Smed: dd_Smed_v6_31751_0_1, dd_Smed_v6_31751_0_1, [RH, Score=47.4, Expect=5e-07]} {RNA1509_36923} {RNA1310_38586} {RNA815_19219} Mlig455_060005 {REF} {Length: 991} {RNA1509_36923} {RNA1310_38586} {RNA815_19219} |
|
| 48. | MligTC455_47712 | 80 | 1.66 | Mlig455_044833 | Neo: - Age: - |
2.831 | - | 0.968 | 0.986 | 0.877 | - | - | Mlig455_044833 {REF} {Length: 564} {RNA1509_55855} {RNA1310_87612} {RNA815_50831} | |
| 49. | MligTC455_40852 | 128 | 2.66 | Mlig455_042301 | Neo: - Age: Up-Up-Down, logFC(26M/2M)=0.671 Region-enriched R2: 6.158/0.00357 |
PKDREJ | 2.827 | - | 0.996 | 0.980 | 0.851 | - | - | Mlig455_042301 {REF} {Length: 11184} {Pfam: Polycystin cation channel [PF08016.14, score=273.5]; PKD domain [PF00801.22, score=86.2]; PLAT/LH2 domain [PF01477.25, score=67.1]; REJ domain [PF02010.17, score=66.8]; PKD domain [PF18911.2, score=62.3]; Ion transport protein [PF00520.33, score=45.4]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=283, Expect=2e-75]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=273, Expect=2e-72]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=158, Expect=3e-38]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=254, Expect=4e-67]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=514, Expect=2e-146]} {RNA1509_8046} {RNA1310_93, RNA1509_8046} {RNA1509_8046, RNA815_1216} |
| 50. | MligTC455_17021 | 49 | 1.02 | Mlig455_030263 | Neo: - Age: - |
2.82 | - | 0.938 | 0.984 | - | 0.898 | - | Mlig455_030263 {REF} {Length: 566} {TRANSSPLICED} {Pfam: Galactosyltransferase [PF01762.23, score=23.7]} {Dmel: FBgn0000221, brn, brainiac, [Score=45.8, Expect=1e-06]} {RNA1310_35735} {RNA815_59866} | |
| 51. | MligTC455_51955 | 32 | 0.67 | Mlig455_004175 | Neo: - Age: - |
2.817 | - | 0.921 | 1.000 | 0.896 | - | - | Mlig455_004175 {REF} {Length: 1877} {Pfam: PLAC8 family [PF04749.19, score=63.3]} {Mouse: ENSMUSG00000029322, Plac8, placenta-specific 8, [Score=50.8, Expect=1e-08]} {Smed: dd_Smed_v6_865_0_1, dd_Smed_v6_865_0_1, [Score=90.1, Expect=8e-24]} {RNA1310_65065} {RNA815_32734} | |
| 52. | MligTC455_30852 | 46 | 0.96 | Mlig455_019345, Mlig455_019563, Mlig455_059135 | Neo: - Age: - |
GRIA2, GRIK2, GRIK4 | 2.799 | 0.867 | - | 0.998 | 0.934 | - | - | Mlig455_019345 {REF} {Length: 3399} {Pfam: Ligand-gated ion channel [PF00060.28, score=95.4]; Receptor family ligand binding region [PF01094.30, score=56.8]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=25.8]; Iron-containing alcohol dehydrogenase [PF13685.8, score=21.9]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=159, Expect=1e-39]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=157, Expect=9e-39]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=159, Expect=7e-40]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=155, Expect=2e-38]} {Dmel: FBgn0039927, CG11155, [Score=160, Expect=3e-40]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [RH, Score=281, Expect=4e-87]} {RNA1509_10728} {RNA1310_122.1} {RNA815_8415.1} Mlig455_019563 {REF} {Length: 2692} {Pfam: Ligand-gated ion channel [PF00060.28, score=91.5]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=98.6, Expect=6e-23]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=95.9, Expect=5e-22]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=94.7, Expect=1e-21]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=96.7, Expect=2e-22]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=95.9, Expect=3e-22]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=94.7, Expect=9e-22]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=92.8, Expect=4e-21]} {Dmel: FBgn0038837, CG3822, [Score=99.4, Expect=2e-23]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=92.8, Expect=2e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=176, Expect=4e-53]} {RNA1310_21734.1} {RNA815_52393} Mlig455_059135 {REF} {Length: 3434} {Pfam: Receptor family ligand binding region [PF01094.30, score=58.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=45.1]; Iron-containing alcohol dehydrogenase [PF13685.8, score=23.1]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=71.6, Expect=2e-12]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=70.5, Expect=3e-12]} {Dmel: FBgn0038837, CG3822, [Score=62.0, Expect=1e-09]} {Celegans: WBGene00001617, glr-6, GLutamate Receptor family (AMPA), [Score=68.6, Expect=6e-12]} {Smed: dd_Smed_v6_41723_0_2, dd_Smed_v6_41723_0_2, [Score=85.1, Expect=8e-18]} {RNA1509_10728} {RNA1310_122.1} {RNA815_8415.1} |
| 53. | MligTC455_43979 | 188 | 3.92 | Mlig455_000082, Mlig455_063749 | Neo: - Age: - |
GHSR | 2.796 | - | 0.849 | 0.993 | - | 0.954 | - | Mlig455_000082 {REF} {Length: 1342} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=53.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Human: ENSG00000121853, GHSR, growth hormone secretagogue receptor, [Score=52.0, Expect=7e-07]} {Mouse: ENSMUSG00000051136, Ghsr, growth hormone secretagogue receptor, [Score=50.4, Expect=2e-06]} {Celegans: WBGene00018798, gnrr-1, GoNadotropin-Releasing hormone Receptor (GnRHR) related, [Score=48.9, Expect=3e-06]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=160, Expect=9e-47]} {RNA1310_30553} Mlig455_063749 {REF} {Length: 1323} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.4]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=157, Expect=1e-45]} {RNA1310_30553} |
| 54. | MligTC455_16974 | 15 | 0.32 | Mlig455_052824 | Neo: - Age: - |
2.794 | - | 0.944 | - | 0.898 | 0.952 | - | Mlig455_052824 {REF} {Length: 306} {NoTransDecoderORF} {RNA1310_65069} {RNA815_35708.2} | |
| 55. | MligTC455_18099 | 24 | 0.51 | Mlig455_036525 | Neo: - Age: - |
PPA1 | 2.794 | - | - | 0.961 | 0.884 | 0.949 | - | Mlig455_036525 {REF} {Length: 1911} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1310_57333.1} {RNA815_22340} |
| 56. | MligTC455_10299 | 72 | 1.51 | Mlig455_023028, Mlig455_023125, Mlig455_023183 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.617 Region-enriched R2: 4.572/0.04281 |
ANGPTL1 | 2.793 | - | 0.934 | 0.979 | 0.880 | - | - | Mlig455_023028 {REF} {Length: 2538} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=130.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=8e-29]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=112, Expect=1e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=114, Expect=2e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=112, Expect=9e-28]} {Dmel: FBgn0050280, CG30280, [Score=103, Expect=9e-26]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.8, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} Mlig455_023125 {REF} {Length: 2398} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=127.5]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=112, Expect=2e-27]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=107, Expect=1e-25]} {Mouse: ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=107, Expect=7e-26]} {Dmel: FBgn0050280, CG30280, [Score=92.8, Expect=6e-22]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=51.2, Expect=3e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} Mlig455_023183 {REF} {Length: 2190} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=2e-28]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=110, Expect=9e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=113, Expect=4e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=110, Expect=6e-27]} {Dmel: FBgn0003326, sca, scabrous, [Score=104, Expect=8e-25]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.4, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} |
| 57. | MligTC455_44308 | 40 | 0.82 | Mlig455_006155 | Neo: - Age: - Region-enriched R2: 5.931/0.03949 |
2.79 | - | 0.924 | 0.959 | 0.907 | - | - | Mlig455_006155 {REF} {Length: 1184} {Pfam: F5/8 type C domain [PF00754.27, score=25.5]} {Smed: dd_Smed_v6_52492_0_1, dd_Smed_v6_52492_0_1, [Score=47.8, Expect=4e-07]} {RNA1509_2129} {RNA1310_49415} {RNA815_42540} | |
| 58. | MligTC455_15663 | 35 | 0.73 | Mlig455_062572 | Neo: - Age: logFC(26M/2M)=1.011 |
2.788 | - | 0.940 | 0.958 | 0.890 | - | - | Mlig455_062572 {REF} {Length: 1735} {Pfam: PAN domain [PF00024.28, score=21.9]} {RNA1310_35902.2} {RNA815_33023} | |
| 59. | MligTC455_50355 | 38 | 0.79 | Mlig455_057631 | Neo: - Age: - Region-enriched R2: 7.639/0.01837 |
2.778 | - | 0.868 | 0.992 | 0.918 | - | - | Mlig455_057631 {REF} {Length: 1003} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=47.4, Expect=6e-06]} {RNA1310_44307} {RNA815_33128} | |
| 60. | MligTC455_12183 | 53 | 1.11 | Mlig455_004166, Mlig455_004190 | Neo: - Age: - Region-enriched R2: 4.930/0.01881 |
2.775 | - | - | 0.963 | 0.892 | 0.920 | - | Mlig455_004166 {REF} {Length: 2818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.4]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=29.1]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=8e-12]} {RNA1310_64973} {RNA815_58453} Mlig455_004190 {REF} {Length: 2742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=28.6]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=56.2, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=1e-11]} {RNA1310_62602} {RNA815_58453} |
|
| 61. | MligTC455_44808 | 20 | 0.41 | Mlig455_013291 | Neo: - Age: - |
2.768 | 0.892 | - | 0.992 | - | 0.884 | - | Mlig455_013291 {REF} {Length: 1358} {RNA1310_28961.1} {RNA815_27532} | |
| 62. | MligTC455_51195 | 51 | 1.06 | Mlig455_020957 | Neo: - Age: Down-Down-Up |
CDK5R1 | 2.768 | - | - | 0.980 | 0.853 | 0.935 | - | Mlig455_020957 {REF} {Length: 1912} {Pfam: Cyclin-dependent kinase 5 activator protein [PF03261.17, score=249.3]} {Human: ENSG00000176749, CDK5R1, cyclin dependent kinase 5 regulatory subunit 1, [RH, Score=191, Expect=5e-57]} {Mouse: ENSMUSG00000048895, Cdk5r1, cyclin-dependent kinase 5, regulatory subunit 1 (p35), [RH, Score=191, Expect=4e-57]} {Dmel: FBgn0027491, Cdk5alpha, Cdk5 activator-like protein, [RH, Score=199, Expect=2e-58]} {Celegans: WBGene00011955, cdka-1, Cyclin-dependent kinase 5 activator 1, [RH, Score=176, Expect=5e-51]} {Smed: dd_Smed_v6_13788_0_1, dd_Smed_v6_13788_0_1, [RH, Score=216, Expect=9e-67]} {RNA1509_28436} {RNA1310_14097} {RNA815_13436} |
| 63. | MligTC455_20015 | 52 | 1.09 | Mlig455_026589 | Neo: - Age: - |
2.747 | - | 0.915 | 0.994 | 0.838 | - | - | Mlig455_026589 {REF} {Length: 611} {RNA1310_66647} {RNA815_33955} | |
| 64. | MligTC455_40617 | 11 | 0.22 | Mlig455_043552 | Neo: - Age: - |
WSCD2 | 2.744 | - | - | 0.999 | 0.812 | 0.933 | - | Mlig455_043552 {REF} {Length: 962} {Pfam: WSC domain [PF01822.21, score=54.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=57.8, Expect=3e-09]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=58.2, Expect=1e-09]} |
| 65. | MligTC455_46881 | 15 | 0.32 | Mlig455_061546 | Neo: - Age: Down-Up-Up |
IAH1 | 2.744 | - | - | 0.998 | 0.865 | 0.881 | - | Mlig455_061546 {REF} {Length: 1647} {Pfam: GDSL-like Lipase/Acylhydrolase family [PF13472.8, score=76.2]; GDSL-like Lipase/Acylhydrolase [PF00657.24, score=32.9]} {Human: ENSG00000134330, IAH1, isoamyl acetate hydrolyzing esterase 1 (putative), [Score=139, Expect=6e-40]} {Mouse: ENSMUSG00000062054, Iah1, isoamyl acetate-hydrolyzing esterase 1 homolog, [Score=122, Expect=1e-33]} {Smed: dd_Smed_v6_6241_0_1, dd_Smed_v6_6241_0_1, [Score=112, Expect=2e-30]} {RNA1310_108127} {RNA815_31492} |
| 66. | MligTC455_42510 | 125 | 2.6 | Mlig455_025998, Mlig455_070424 | Neo: - |
2.742 | - | 0.883 | 0.967 | 0.892 | - | - | Mlig455_025998 {REF} {Length: 1369} {RNA1310_73875.1} Mlig455_070424 {REF} {Length: 1082} {RNA1310_73875.1} |
|
| 67. | MligTC455_50594 | 440 | 9.18 | Mlig455_010362 | Neo: - Age: Down-Up-Up Region-specific R2: 4.701 Region-enriched R2: 4.104/0.00000 |
2.732 | - | 0.976 | - | 0.887 | 0.869 | - | Mlig455_010362 {REF} {Length: 685} {RNA1509_30018} {RNA1310_56512.2} {RNA815_28562} | |
| 68. | MligTC455_32644 | 41 | 0.86 | Mlig455_043770, Mlig455_043786 | Neo: - Age: - Region-enriched R2: 6.705/0.00336 |
2.726 | - | 0.933 | 0.998 | - | 0.795 | - | Mlig455_043770 {REF} {Length: 1011} {Pfam: PAN domain [PF00024.28, score=19.3]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=60.8, Expect=3e-11]} {RNA1509_35604} {RNA1310_57814} {RNA815_29718} Mlig455_043786 {REF} {Length: 1348} {Pfam: PAN domain [PF00024.28, score=19.3]} {RNA1509_35604} {RNA1310_34182} {RNA815_29718} |
|
| 69. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 2.718 | - | - | 0.838 | 0.925 | 0.955 | - | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |
| 70. | MligTC455_40119 | 114 | 2.37 | Mlig455_034596 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.158/0.00258 |
KCNIP1 | 2.716 | - | 0.962 | 0.848 | - | 0.906 | - | Mlig455_034596 {REF} {Length: 1987} {Pfam: EF-hand domain pair [PF13499.8, score=42.4]; EF hand [PF00036.34, score=38.6]; EF-hand domain [PF13405.8, score=33.5]; EF hand [PF13202.8, score=31.2]; EF-hand domain pair [PF13833.8, score=28.7]} {Human: ENSG00000182132, KCNIP1, potassium voltage-gated channel interacting protein 1, [Score=122, Expect=3e-32]; ENSG00000185774, KCNIP4, potassium voltage-gated channel interacting protein 4, [Score=122, Expect=2e-32]; ENSG00000115041, KCNIP3, potassium voltage-gated channel interacting protein 3, [Score=119, Expect=1e-30]} {Mouse: ENSMUSG00000053519, Kcnip1, Kv channel-interacting protein 1, [Score=124, Expect=5e-33]; ENSMUSG00000029088, Kcnip4, Kv channel interacting protein 4, [Score=122, Expect=1e-32]} {Dmel: FBgn0013303, Nca, Neurocalcin, [Score=100, Expect=6e-25]} {Celegans: WBGene00003563, ncs-1, Neuronal calcium sensor 1, [Score=103, Expect=6e-26]} {Smed: dd_Smed_v6_9727_0_1, dd_Smed_v6_9727_0_1, [Score=122, Expect=7e-33]} {RNA1310_43225} {RNA815_33406} |
| 71. | MligTC455_13130 | 40 | 0.83 | Mlig455_032511, Mlig455_068691 | Neo: - Age: - |
WSCD2 | 2.714 | - | 0.986 | 0.931 | 0.797 | - | - | Mlig455_032511 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=40.9]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.4, Expect=6e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {RNA1310_39527} {RNA815_19067} Mlig455_068691 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=41.8]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.1, Expect=1e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=49.7, Expect=9e-07]; ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=4e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=62.0, Expect=6e-11]} {RNA1310_39527} {RNA815_19067} |
| 72. | MligTC455_32028 | 19 | 0.39 | Mlig455_019343, Mlig455_019346 | Neo: - Age: - |
GRIA2 | 2.712 | - | - | 0.995 | 0.888 | 0.829 | - | Mlig455_019343 {REF} {Length: 3241} {Pfam: Ligand-gated ion channel [PF00060.28, score=96.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=57.9]; Receptor family ligand binding region [PF01094.30, score=49.1]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.0]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=150, Expect=1e-36]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=149, Expect=2e-36]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=146, Expect=2e-35]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=144, Expect=9e-35]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=144, Expect=1e-34]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=150, Expect=5e-37]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=150, Expect=8e-37]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=145, Expect=3e-35]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=145, Expect=3e-35]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=144, Expect=5e-35]} {Dmel: FBgn0039927, CG11155, [Score=158, Expect=1e-39]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=125, Expect=3e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=250, Expect=2e-75]} {RNA1509_10728} {RNA1310_4026} {RNA815_8415.1} Mlig455_019346 {REF} {Length: 519} {Pfam: Receptor family ligand binding region [PF01094.30, score=21.5]} {RNA1509_10728} {RNA1310_4026} {RNA815_8415.2} |
| 73. | MligTC455_38875 | 37 | 0.78 | Mlig455_029375, Mlig455_029415 | Neo: - Age: logFC(26M/2M)=-0.939 |
GRIK2 | 2.707 | - | - | 0.999 | 0.910 | 0.798 | - | Mlig455_029375 {REF} {Length: 3713} {Pfam: Ligand-gated ion channel [PF00060.28, score=88.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=58.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=34.5]; Receptor family ligand binding region [PF01094.30, score=20.4]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=136, Expect=2e-32]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=137, Expect=9e-33]} {Dmel: FBgn0038837, CG3822, [Score=150, Expect=4e-37]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=242, Expect=3e-72]} {RNA1310_67049} {RNA815_49856} Mlig455_029415 {REF} {Length: 2520} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=25.5]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=73.9, Expect=5e-14]} {RNA1310_74947} {RNA815_49856} |
| 74. | MligTC455_19583 | 95 | 1.97 | Mlig455_010583, Mlig455_010602 | Neo: - Age: - Region-enriched R2: 6.442/0.00383 |
2.705 | - | 0.972 | - | 0.846 | 0.887 | - | Mlig455_010583 {REF} {Length: 2325} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=173.5]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [Score=320, Expect=4e-101]} {RNA1310_36131} {RNA815_32135} Mlig455_010602 {REF} {Length: 2432} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=182.9]} {Smed: dd_Smed_v6_15099_0_1, dd_Smed_v6_15099_0_1, [RH, Score=346, Expect=2e-110]} {RNA1310_36131} {RNA815_32135} |
|
| 75. | MligTC455_40388 | 23 | 0.47 | Mlig455_019615 | Neo: - Age: - |
2.704 | - | - | 0.834 | 0.920 | 0.950 | - | Mlig455_019615 {REF} {Length: 2102} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=34.2]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=144, Expect=9e-37]} {RNA1310_29891} {RNA815_15562} | |
| 76. | MligTC455_41035 | 366 | 7.62 | Mlig455_000866 | Neo: - Age: logFC(26M/2M)=-0.773 Region-specific R2: 5.029 Region-enriched R2: 4.768/0.00000 |
2.699 | - | 0.959 | 0.819 | 0.921 | - | - | Mlig455_000866 {REF} {Length: 1126} {Pfam: Pancreatic hormone peptide [PF00159.20, score=41.6]} {RNA1509_27581} {RNA1310_74103, RNA1509_27581} {RNA1509_27581, RNA815_38377} | |
| 77. | MligTC455_52120 | 179 | 3.73 | Mlig455_024423, Mlig455_024577 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.068/0.01755 |
POU4F3 | 2.699 | - | 0.919 | 0.974 | - | 0.806 | - | Mlig455_024423 {REF} {Length: 1288} {TRANSSPLICED} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=104.8]; Homeodomain [PF00046.31, score=60.9]} {Human: ENSG00000091010, POU4F3, POU class 4 homeobox 3, [Score=212, Expect=1e-65]; ENSG00000152192, POU4F1, POU class 4 homeobox 1, [Score=211, Expect=2e-64]} {Mouse: ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [Score=212, Expect=7e-66]; ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [Score=211, Expect=2e-64]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [Score=209, Expect=2e-64]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [Score=188, Expect=4e-57]} {Smed: dd_Smed_v6_30562_0_1, dd_Smed_v6_30562_0_1, [Score=208, Expect=2e-64]} {RNA1509_57422} {RNA1310_23131} {RNA815_34447} Mlig455_024577 {REF} {Length: 1325} {TRANSSPLICED} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=104.8]; Homeodomain [PF00046.31, score=60.9]} {Human: ENSG00000091010, POU4F3, POU class 4 homeobox 3, [Score=212, Expect=1e-65]; ENSG00000152192, POU4F1, POU class 4 homeobox 1, [Score=211, Expect=2e-64]} {Mouse: ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [Score=212, Expect=7e-66]; ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [Score=211, Expect=2e-64]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [Score=209, Expect=2e-64]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [Score=188, Expect=4e-57]} {Smed: dd_Smed_v6_30562_0_1, dd_Smed_v6_30562_0_1, [Score=208, Expect=2e-64]} {RNA1509_57422} {RNA1310_23131} {RNA815_34447} |
| 78. | MligTC455_39838 | 117 | 2.44 | Mlig455_061337, Mlig455_062688 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.720/0.01251 |
PROP1 | 2.697 | - | 0.835 | 0.967 | 0.895 | - | - | Mlig455_061337 {REF} {Length: 2182} {Pfam: Homeodomain [PF00046.31, score=77.0]} {Human: ENSG00000175325, PROP1, PROP paired-like homeobox 1, [RH, Score=97.8, Expect=9e-23]; ENSG00000274382, PROP1, PROP paired-like homeobox 1, [RH, Score=97.8, Expect=9e-23]} {Mouse: ENSMUSG00000028736, Pax7, paired box 7, [Score=103, Expect=4e-23]; ENSMUSG00000036602, Alx1, ALX homeobox 1, [Score=102, Expect=4e-24]; ENSMUSG00000024518, Rax, retina and anterior neural fold homeobox, [Score=101, Expect=3e-23]; ENSMUSG00000035277, Arx, aristaless related homeobox, [Score=100, Expect=4e-22]; ENSMUSG00000040310, Alx4, aristaless-like homeobox 4, [Score=100, Expect=9e-23]; ENSMUSG00000014603, Alx3, aristaless-like homeobox 3, [Score=99.0, Expect=2e-22]} {Dmel: FBgn0052532, CG32532, [RH, Score=188, Expect=3e-55]} {Celegans: WBGene00006778, unc-42, [RH, Score=152, Expect=1e-42]} {Smed: dd_Smed_v6_21801_0_1, dd_Smed_v6_21801_0_1, [RH, Score=211, Expect=9e-63]} {RNA1310_35015.1} {RNA815_23154} Mlig455_062688 {REF} {Length: 2531} {Pfam: Homeodomain [PF00046.31, score=77.5]} {Human: ENSG00000274382, PROP1, PROP paired-like homeobox 1, [RH, Score=99.0, Expect=1e-23]; ENSG00000175325, PROP1, PROP paired-like homeobox 1, [RH, Score=99.0, Expect=1e-23]} {Mouse: ENSMUSG00000036602, Alx1, ALX homeobox 1, [Score=103, Expect=5e-25]; ENSMUSG00000028736, Pax7, paired box 7, [Score=103, Expect=5e-24]; ENSMUSG00000024518, Rax, retina and anterior neural fold homeobox, [Score=102, Expect=4e-24]; ENSMUSG00000040310, Alx4, aristaless-like homeobox 4, [Score=102, Expect=8e-24]; ENSMUSG00000035277, Arx, aristaless related homeobox, [Score=101, Expect=4e-23]; ENSMUSG00000014603, Alx3, aristaless-like homeobox 3, [Score=100, Expect=2e-23]; ENSMUSG00000004872, Pax3, paired box 3, [Score=99.4, Expect=2e-22]; ENSMUSG00000012520, Phox2b, paired-like homeobox 2b, [Score=98.2, Expect=7e-23]} {Dmel: FBgn0052532, CG32532, [RH, Score=189, Expect=2e-56]} {Celegans: WBGene00006778, unc-42, [RH, Score=155, Expect=1e-44]} {Smed: dd_Smed_v6_21801_0_1, dd_Smed_v6_21801_0_1, [RH, Score=212, Expect=2e-64]} {RNA1310_35015.1} {RNA815_23154} |
| 79. | MligTC455_41540 | 190 | 3.96 | Mlig455_060056 | Neo: - Age: - Region-enriched R2: 6.605/0.00196 |
GLUL | 2.697 | - | 0.994 | 0.987 | 0.716 | - | - | Mlig455_060056 {REF} {Length: 1355} {Pfam: Glutamine synthetase, catalytic domain [PF00120.26, score=57.3]; Glutamine synthetase, beta-Grasp domain [PF03951.21, score=47.5]} {Human: ENSG00000135821, GLUL, glutamate-ammonia ligase, [RH, Score=511, Expect=1e-180]} {Mouse: ENSMUSG00000026473, Glul, glutamate-ammonia ligase (glutamine synthetase), [RH, Score=511, Expect=0.0]} {Dmel: FBgn0001145, Gs2, Glutamine synthetase 2, [RH, Score=511, Expect=0.0]} {Celegans: WBGene00001604, gln-3, Glutamine synthetase, [RH, Score=515, Expect=0.0]} {Smed: dd_Smed_v6_896_0_1, dd_Smed_v6_896_0_1, [RH, Score=545, Expect=0.0]} {RNA1509_47000} {RNA1310_22329.2} {RNA815_4116.6} |
| 80. | MligTC455_48063 | 63 | 1.31 | Mlig455_046268 | Neo: - Age: - Region-enriched R2: 5.256/0.00170 |
2.696 | - | 0.988 | - | 0.865 | 0.843 | - | Mlig455_046268 {REF} {Length: 749} {RNA1310_88363} {RNA815_47885} | |
| 81. | MligTC455_50704 | 36 | 0.74 | Mlig455_007321, Mlig455_068329 | Neo: - Age: - |
2.686 | - | 0.966 | 0.861 | - | 0.859 | - | Mlig455_007321 {REF} {Length: 1784} {RNA815_63232} Mlig455_068329 {REF} {Length: 1748} {RNA815_63232} |
|
| 82. | MligTC455_53681 | 335 | 6.99 | Mlig455_064921 | Neo: - Age: - Region-enriched R2: 6.469/0.00000 |
2.685 | - | 0.992 | 0.941 | 0.752 | - | - | Mlig455_064921 {REF} {Length: 1504} {Pfam: PAN domain [PF00024.28, score=19.3]} {RNA1310_33258} {RNA815_17150} | |
| 83. | MligTC455_17568 | 33 | 0.68 | Mlig455_059349, Mlig455_065584 | Neo: - Age: - |
2.684 | - | 0.944 | 0.969 | - | 0.771 | - | Mlig455_059349 {REF} {Length: 1132} {RNA1509_24218} {RNA1310_25312.1} {RNA815_12390} Mlig455_065584 {REF} {Length: 1132} {RNA1509_24218} {RNA1310_25312.1} {RNA815_12390} |
|
| 84. | MligTC455_20091 | 41 | 0.85 | Mlig455_053591 | Neo: - Age: - |
TNN | 2.68 | - | 0.996 | 0.971 | 0.713 | - | - | Mlig455_053591 {REF} {Length: 1556} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=132.6]; PAN domain [PF00024.28, score=21.9]} {Human: ENSG00000120332, TNN, tenascin N, [Score=105, Expect=8e-25]} {Mouse: ENSMUSG00000026725, Tnn, tenascin N, [Score=102, Expect=9e-24]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=99.4, Expect=7e-24]; ENSMUSG00000026938, Fcna, ficolin A, [Score=97.8, Expect=4e-23]} {Dmel: FBgn0050280, CG30280, [Score=108, Expect=1e-27]} {Celegans: WBGene00016769, C49C8.5, [Score=46.2, Expect=1e-05]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=112, Expect=6e-28]} {RNA1310_44715} {RNA815_35355} |
| 85. | MligTC455_49434 | 157 | 3.26 | Mlig455_068252, Mlig455_068272 | Neo: - Age: - |
2.676 | - | - | 0.939 | 0.787 | 0.950 | - | Mlig455_068252 {REF} {Length: 718} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.5, Expect=1e-12]} {RNA1310_75052} Mlig455_068272 {REF} {Length: 1055} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.2, Expect=2e-12]} {RNA1310_75052} |
|
| 86. | MligTC455_10018 | 16 | 0.32 | Mlig455_034726, Mlig455_067577 | Neo: - Age: - |
GUCY2D, GUCY2F | 2.672 | - | - | 0.814 | 0.906 | 0.952 | - | Mlig455_034726 {REF} {Length: 4473} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.6]; Protein kinase domain [PF00069.27, score=72.8]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=632, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=640, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=707, Expect=0.0]} {RNA1310_64185} {RNA815_57442} Mlig455_067577 {REF} {Length: 474} {Human: ENSG00000132518, GUCY2D, guanylate cyclase 2D, retinal, [Score=66.2, Expect=9e-13]} {Mouse: ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=65.1, Expect=2e-12]} {Dmel: FBgn0085386, CG34357, [Score=62.0, Expect=1e-11]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [Score=44.7, Expect=9e-06]} {Smed: dd_Smed_v6_39042_0_1, dd_Smed_v6_39042_0_1, [Score=98.2, Expect=2e-25]} {RNA1310_101378} |
| 87. | MligTC455_42840 | 147 | 3.06 | Mlig455_003645 | Neo: - Age: - |
2.672 | - | 0.956 | 0.978 | - | 0.738 | - | Mlig455_003645 {REF} {Length: 1270} {RNA1509_48973} {RNA1310_36721} {RNA815_36286} | |
| 88. | MligTC455_44954 | 1303 | 27.14 | Mlig455_029595, Mlig455_070648 | Neo: Int S/G2/M Age: Down-Up-Up, logFC(26M/2M)=1.023 Region-specific R2: 8.846 Region-enriched R2: 10.764/0.00000 |
2.656 | - | 0.783 | - | 0.909 | 0.964 | - | Mlig455_029595 {REF} {Length: 484} {Pfam: Pancreatic hormone peptide [PF00159.20, score=30.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.4, Expect=3e-08]} {RNA1509_20871} {RNA1310_66833.2} {RNA815_41767} Mlig455_070648 {REF} {Length: 484} {Pfam: Pancreatic hormone peptide [PF00159.20, score=30.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.4, Expect=3e-08]} {RNA1509_20871, RNA1509_39484} {RNA1310_66833.2, RNA1509_20871, RNA1509_39484} {RNA1509_20871, RNA1509_39484, RNA815_41767} |
|
| 89. | MligTC455_13799 | 33 | 0.69 | Mlig455_042825, Mlig455_063144 | Neo: - Age: - |
GRIA2, GRIK1 | 2.644 | - | - | 0.871 | 0.809 | 0.964 | - | Mlig455_042825 {REF} {Length: 2617} {Pfam: Ligand-gated ion channel [PF00060.28, score=107.4]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=42.5]; Receptor family ligand binding region [PF01094.30, score=28.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=27.3]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=147, Expect=5e-36]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=142, Expect=2e-34]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=141, Expect=3e-34]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=140, Expect=8e-34]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=140, Expect=1e-33]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=147, Expect=4e-36]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=143, Expect=6e-35]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=141, Expect=3e-34]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=140, Expect=5e-34]} {Dmel: FBgn0039927, CG11155, [Score=160, Expect=1e-40]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=130, Expect=3e-31]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=238, Expect=1e-71]} {RNA1310_25150} {RNA815_13999} Mlig455_063144 {REF} {Length: 2554} {Pfam: Ligand-gated ion channel [PF00060.28, score=107.4]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=42.6]; Receptor family ligand binding region [PF01094.30, score=31.9]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=27.5]} {Human: ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=150, Expect=4e-37]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=147, Expect=4e-36]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=147, Expect=3e-36]} {Mouse: ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=152, Expect=9e-38]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=147, Expect=4e-36]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=145, Expect=1e-35]} {Dmel: FBgn0038837, CG3822, [Score=162, Expect=2e-41]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=130, Expect=3e-31]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=238, Expect=9e-72]} {RNA1310_25150} {RNA815_13999} |
| 90. | MligTC455_50347 | 549 | 11.43 | Mlig455_012382 | Neo: - Age: Down-Up-Up Region-specific R2: 6.390 Region-enriched R2: 6.623/0.00000 |
2.642 | - | 0.954 | 0.833 | - | 0.855 | - | Mlig455_012382 {REF} {Length: 797} {RNA1509_48155} {RNA1310_70969.2, RNA1509_48155} {RNA1509_48155, RNA815_39712} | |
| 91. | MligTC455_53869 | 27 | 0.57 | Mlig455_060247 | Neo: - Age: - |
CHDH | 2.64 | - | - | 0.770 | 0.919 | 0.951 | - | Mlig455_060247 {REF} {Length: 2837} {Pfam: GMC oxidoreductase [PF00732.21, score=82.3]; GMC oxidoreductase [PF05199.15, score=61.5]; FAD dependent oxidoreductase [PF01266.26, score=20.3]; Lycopene cyclase protein [PF05834.14, score=18.0]} {Human: ENSG00000016391, CHDH, choline dehydrogenase, [Score=101, Expect=6e-22]} {Mouse: ENSMUSG00000015970, Chdh, choline dehydrogenase, [Score=103, Expect=9e-23]} {Dmel: FBgn0037896, ninaG, [Score=116, Expect=3e-27]} {Celegans: WBGene00007917, C34C6.4, [Score=65.9, Expect=4e-11]} {Smed: dd_Smed_v6_13047_0_2, dd_Smed_v6_13047_0_2, [RH, Score=166, Expect=2e-44]} {RNA1310_47881.1} |
| 92. | MligTC455_01652 | 149 | 3.1 | Mlig455_018970 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.522/0.03301 |
2.637 | 0.865 | - | - | 0.813 | 0.959 | - | Mlig455_018970 {REF} {Length: 756} {Pfam: Pancreatic hormone peptide [PF00159.20, score=41.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [Score=40.0, Expect=7e-06]} {RNA1310_45503} {RNA815_39878} | |
| 93. | MligTC455_40340 | 201 | 4.19 | Mlig455_021026, Mlig455_021062 | Neo: - Age: - |
2.633 | - | - | 0.890 | 0.784 | 0.959 | - | Mlig455_021026 {REF} {Length: 1609} {RNA1310_21018} {RNA815_22069} Mlig455_021062 {REF} {Length: 1582} {RNA1310_21018} {RNA815_22069} |
|
| 94. | MligTC455_45496 | 144 | 2.99 | Mlig455_010048 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.720/0.00332 |
CAV2 | 2.628 | - | 0.938 | 0.966 | 0.724 | - | - | Mlig455_010048 {REF} {Length: 2607} {Pfam: Caveolin [PF01146.19, score=125.0]} {Human: ENSG00000105971, CAV2, caveolin 2, [Score=85.5, Expect=3e-21]} {Mouse: ENSMUSG00000000058, Cav2, caveolin 2, [Score=89.4, Expect=7e-23]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=79.0, Expect=2e-18]} {Smed: dd_Smed_v6_8555_0_1, dd_Smed_v6_8555_0_1, [RH, Score=153, Expect=1e-48]} {RNA1509_20287} {RNA1310_50581.1, RNA1509_20287} {RNA1509_20287, RNA815_31873} |
| 95. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
2.627 | 0.762 | - | - | 0.909 | 0.956 | - | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
| 96. | MligTC455_52232 | 92 | 1.92 | Mlig455_007894, Mlig455_008001 | Neo: - Age: logFC(26M/2M)=0.549 |
2.623 | - | 0.944 | 0.967 | 0.712 | - | - | Mlig455_007894 {REF} {Length: 1500} {RNA1310_22136} {RNA815_18832} Mlig455_008001 {REF} {Length: 1450} {Pfam: PAN domain [PF00024.28, score=18.9]} {RNA1310_22136} {RNA815_18832} |
|
| 97. | MligTC455_46451 | 229 | 4.76 | Mlig455_017183 | Neo: - Age: Down-Up-Down Region-specific R2: 5.510 Region-enriched R2: 5.394/0.00018 Regeneration-downregulated R2: -2.986 Regeneration-depleted R2: -2.986 |
2.621 | - | 0.776 | - | 0.892 | 0.953 | - | Mlig455_017183 {REF} {Length: 657} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.6]} {RNA1310_62963} {RNA815_31352} | |
| 98. | MligTC455_12545 | 37 | 0.76 | Mlig455_069121 | Neo: - Age: - |
2.617 | - | 0.811 | - | 0.851 | 0.955 | - | Mlig455_069121 {REF} {Length: 1966} {RNA1310_47776.1} {RNA815_35125} | |
| 99. | MligTC455_42580 | 98 | 2.04 | Mlig455_014929, Mlig455_045199 | Neo: - Age: - |
NKX2-2 | 2.616 | - | - | 0.870 | 0.794 | 0.952 | - | Mlig455_014929 {REF} {Length: 1652} {Pfam: Homeodomain [PF00046.31, score=70.3]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=138, Expect=2e-37]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=1e-37]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=4e-35]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=107, Expect=6e-26]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=1e-29]} {RNA1310_42496} {RNA815_52707} Mlig455_045199 {REF} {Length: 1211} {Pfam: Homeodomain [PF00046.31, score=71.0]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=139, Expect=6e-39]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=3e-39]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=1e-36]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=108, Expect=2e-27]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=7e-31]} {RNA1310_42496} {RNA815_52707} |
| 100. | MligTC455_45039 | 168 | 3.49 | Mlig455_040482, Mlig455_040487 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.332/0.02336 |
2.616 | - | 0.897 | 0.956 | 0.763 | - | - | Mlig455_040482 {REF} {Length: 1774} {RNA1310_20941} {RNA815_45079} Mlig455_040487 {REF} {Length: 5763} {tRNA: Val(CAC),pseudo, score=20.2} {Celegans: WBGene00022195, Y71H2B.5, [Score=146, Expect=8e-36]} {Smed: dd_Smed_v6_16438_0_2, dd_Smed_v6_16438_0_2, [Score=188, Expect=1e-49]} {RNA1509_21228} {RNA1310_20941} {RNA815_45079} |
There are 609 more genes with r >= 0.95